Seller record · Telehealth service

Remedy Meds

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: Each mention names only licensed United States pharmacies as a category. The terms, privacy, telehealth consent, safety, careers and footer surfaces add no facility. 3 more criteria also fail; see the table below.

At a glance

Remedy MedsTelehealth service

4/8criteria passed

Price: Not printed before a consultation or sign-up
Sells: compounded semaglutide, compounded tirzepatide
FDA letters: 1 on file

Visit Remedy Meds See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide on a membership that bundles medication with clinician access. It prints no price on any public page, and the street address it withholds appears in the FDA letter addressed to it.

Operating entity Remedy Meds LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Remedy Meds' terms of service page
S2	Prescription gating	PASS	Remedy Meds' quiz page
S3	Pharmacy identification	FAIL	Remedy Meds' privacy policy
S4	Compounding disclosure	PASS	Remedy Meds' website
S5	Analytical documentation	FAIL	Remedy Meds' website
S6	Business address	FAIL	Remedy Meds' terms of service page
S7	Price disclosure	FAIL	Remedy Meds' quiz page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe terms state that medical evaluation, diagnosis, treatment decisions and prescribing are provided solely by licensed clinicians through the professional entities.Source: Remedy Meds' terms of service page.

S2PASSNine screens of health questions covering goals, height, weight, pace and eligibility come before any product page or payment field.Source: Remedy Meds' quiz page.

S3FAILEach mention names only licensed United States pharmacies as a category. The terms, privacy, telehealth consent, safety, careers and footer surfaces add no facility.Source: Remedy Meds' privacy policy.

S4PASSThe homepage disclosure states that the products are compounded and that the Food and Drug Administration has not evaluated them for safety, quality or efficacy.Source: Remedy Meds' website.

S5FAILThe homepage prints four named tests marked passed, covering potency, sterility, pH and endotoxicity, and it names no laboratory, no lot and no document.Source: Remedy Meds' website.

S6FAILThe site prints no street address. Footer, terms, privacy, telehealth consent, safety and careers give a telephone number and an email address instead.Source: Remedy Meds' terms of service page.

S7FAILNo price appears anywhere on the site, and none appears across the nine intake screens before the eligibility questions.Source: Remedy Meds' quiz page.

S8PASSFDA warning letter 716830, September 2025, names Remedy Meds at a Summit, New Jersey street address the site itself does not publish, and cites claims of the same active ingredient as an approved drug. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 716830, issued September 2025, to Remedy MedsClaims on Remedy Meds' website that compounded semaglutide and tirzepatide are the same active ingredient as four approved brands are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Remedy Meds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.